Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction01:22

Dementia l: Introduction

35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning and multi-statistical features: an intra-frame forgery detection video method.

Frontiers in artificial intelligence·2026
Same author

EEG-based harmful brain activity classification using deep learning and feature fusion.

Scientific reports·2026
Same author

Voltammetric Analysis of Quasi-Reversible Kinetics in Aptamer Self-Assembled Monolayers: Toward Rational E-AB Sensor Design.

ACS sensors·2026
Same author

Using transfer learning approaches to predict RNA-Seq gene expression data for cancer classification.

Frontiers in artificial intelligence·2026
Same author

A robust deep learning approach for impulse noise filtering using hybrid auto-encoder with fuzzy median filter.

PloS one·2026
Same author

Ensemble Deep Learning-Based High-Precision Framework for Breast Cancer Detection from Histopathological Images.

Diagnostics (Basel, Switzerland)·2026
Same journal

Performance of large language models as an information resource on functional hypothalamic amenorrhea for patients and healthcare professionals.

Frontiers in artificial intelligence·2026
Same journal

<i>S</i> <sup>3</sup>Net: a Synthesis-Segmentation-Spiking Network for Alzheimer's disease detection and segmentation.

Frontiers in artificial intelligence·2026
Same journal

Machine learning-based insurance risk assessment pipeline for natural disaster prediction and claims estimation.

Frontiers in artificial intelligence·2026
Same journal

Early Alzheimer's risk detection via diffusion tensor imaging using a few-shot multichannel attention residual learning network.

Frontiers in artificial intelligence·2026
Same journal

An interpretable machine learning framework for classifying human and machine translations across genres.

Frontiers in artificial intelligence·2026
Same journal

AI-driven financial risk management in complex mobile economies: a contextual-technology fit and security reassurance model.

Frontiers in artificial intelligence·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K

Gender-based Alzheimer's detection using ResNet-50 and binary dragonfly algorithm on neuroimaging.

Muhammad Ikram Ul Haq1,2, Waqas Haider Bangyal3, Arfan Jaffar1

  • 1Department of Software Engineering, Superior University, Lahore, Pakistan.

Frontiers in Artificial Intelligence
|December 24, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a gender-based Alzheimer's detection model using fMRI data and machine learning. The GRDN model achieved 94.8% accuracy in identifying Alzheimer's in males, highlighting the importance of gender in diagnosis.

Keywords:
ADNIAlzheimer's diseasefMRIgenderpretrained

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer&#39;s Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.3K

Related Experiment Videos

Last Updated: May 3, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer&#39;s Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.3K

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a silent onset, making early diagnosis challenging.
  • Existing research shows AD risk varies by gender, age, race, and ethnicity, yet gender-based studies are lacking.
  • Accurate diagnosis of Alzheimer's requires sophisticated algorithms to detect subtle brain changes.

Purpose of the Study:

  • To propose and evaluate a gender-based Alzheimer's detection model (GRDN) using functional magnetic resonance imaging (fMRI).
  • To explore the impact of gender on Alzheimer's detection accuracy using machine learning.
  • To enhance classifier performance on underrepresented groups through data balancing techniques.

Main Methods:

  • Utilized fMRI data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
  • Employed a generative adversarial network (GAN) for data balancing and a ResNet-50 architecture for feature extraction.
  • Applied the binary dragonfly algorithm (BDA) for feature selection, followed by five machine learning classifiers.

Main Results:

  • Increased feature set size correlated with improved classification accuracy.
  • The fineKNN classifier achieved a high accuracy of 94.8% for the male group with a feature set of 450.
  • The proposed model demonstrated consistent performance across different study groups, outperforming other models.

Conclusions:

  • The GRDN model shows significant potential for gender-based Alzheimer's detection.
  • Feature engineering and selection are crucial for enhancing diagnostic accuracy in Alzheimer's.
  • Further research into gender-specific risk factors and diagnostic approaches is warranted.